Daniel Cramer

21.1k total citations
23 papers, 785 citations indexed

About

Daniel Cramer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daniel Cramer has authored 23 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Daniel Cramer's work include Polysaccharides and Plant Cell Walls (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and T-cell and B-cell Immunology (5 papers). Daniel Cramer is often cited by papers focused on Polysaccharides and Plant Cell Walls (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and T-cell and B-cell Immunology (5 papers). Daniel Cramer collaborates with scholars based in United States, United Kingdom and Poland. Daniel Cramer's co-authors include Jun Yan, Richard Hansen, Chuanlin Ding, Daniel J. Allendorf, José L. Marroquín, Bing Li, Suzanne T. Ildstad, Yiming Huang, Mariusz Z. Ratajczak and Bing Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Daniel Cramer

23 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Cramer United States 14 363 175 164 160 127 23 785
Benjamin P. Thornton United States 7 541 1.5× 287 1.6× 270 1.6× 61 0.4× 60 0.5× 9 1.2k
Yoshiaki Fujimiya Japan 15 268 0.7× 158 0.9× 177 1.1× 113 0.7× 44 0.3× 29 890
Margareta Hanikýřová United States 7 248 0.7× 149 0.9× 110 0.7× 38 0.2× 32 0.3× 8 567
Judith A. Cain United States 10 405 1.1× 126 0.7× 172 1.0× 39 0.2× 78 0.6× 12 826
J.P. Pivel Spain 14 335 0.9× 101 0.6× 251 1.5× 78 0.5× 45 0.4× 28 1.1k
Ling Zeng China 17 286 0.8× 146 0.8× 394 2.4× 53 0.3× 55 0.4× 52 1.0k
Kayoko Suzuki Japan 17 118 0.3× 70 0.4× 170 1.0× 45 0.3× 46 0.4× 82 891
Rong‐Hwa Lin Taiwan 18 563 1.6× 147 0.8× 303 1.8× 176 1.1× 19 0.1× 30 1.3k
Guang‐Yuh Hwang Taiwan 18 87 0.2× 66 0.4× 250 1.5× 106 0.7× 61 0.5× 45 907
T Taniyama Japan 16 458 1.3× 37 0.2× 354 2.2× 205 1.3× 24 0.2× 29 975

Countries citing papers authored by Daniel Cramer

Since Specialization
Citations

This map shows the geographic impact of Daniel Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Cramer more than expected).

Fields of papers citing papers by Daniel Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Cramer. The network helps show where Daniel Cramer may publish in the future.

Co-authorship network of co-authors of Daniel Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Cramer. A scholar is included among the top collaborators of Daniel Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Cramer. Daniel Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bares, Sara H, Kimberly K. Scarsi, Anthony T. Podany, et al.. (2025). Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report. Open Forum Infectious Diseases. 12(7). ofaf399–ofaf399. 1 indexed citations
2.
Warawa, Jonathan M., Xiaoxian Duan, Charles D. Anderson, et al.. (2022). Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains. Microbiology Spectrum. 10(5). e0269322–e0269322. 5 indexed citations
3.
Engel, Peter A., Andrzej Słomiński, Bruce D. Ragsdale, et al.. (2016). Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case–Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors. American Journal of Dermatopathology. 39(3). 189–194. 12 indexed citations
4.
Golden, Jennifer E., Robert S. Adcock, Chad E. Schroeder, et al.. (2016). Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State. Antimicrobial Agents and Chemotherapy. 60(8). 4552–4562. 44 indexed citations
5.
Lawrenz, Matthew B., et al.. (2015). Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing. Pathogens and Disease. 73(5). 11 indexed citations
6.
Perez‐Abadia, Gustavo, Sathnur Pushpakumar, Daniel Cramer, et al.. (2010). Cell Membrane Modification for Rapid Display of Bi-Functional Peptides: A Novel Approach to Reduce Complement Activation. The Open Cardiovascular Medicine Journal. 4(1). 157–165. 1 indexed citations
7.
Hansen, Richard, et al.. (2009). Therapeutic potential of various β-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biology & Therapy. 8(3). 218–225. 59 indexed citations
8.
Chesney, Jason, Mary Ann Rasku, Amy Clem, et al.. (2008). Transient T-cell depletion causes regression of melanoma metastases. Journal of Clinical Oncology. 26(15_suppl). 9030–9030. 2 indexed citations
9.
Rasku, Mary Ann, Amy Clem, Sucheta Telang, et al.. (2008). Transient T cell depletion causes regression of melanoma metastases. Journal of Translational Medicine. 6(1). 12–12. 118 indexed citations
10.
Salvador, Carolina, Bing Li, Richard Hansen, et al.. (2008). Yeast-Derived β-Glucan Augments the Therapeutic Efficacy Mediated by Anti–Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models. Clinical Cancer Research. 14(4). 1239–1247. 41 indexed citations
11.
Cramer, Daniel, Stephanie A. Wagner, Bing Li, et al.. (2008). Mobilization of Hematopoietic Progenitor Cells by Yeast-Derivedβ-Glucan Requires Activation of Matrix Metalloproteinase-9. Stem Cells. 26(5). 1231–1240. 26 indexed citations
12.
Li, Bing, Daniel Cramer, Stephanie A. Wagner, et al.. (2007). Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways. Clinical Immunology. 124(2). 170–181. 58 indexed citations
13.
Li, Bing, Daniel J. Allendorf, Richard Hansen, et al.. (2007). Combined Yeast β-Glucan and Antitumor Monoclonal Antibody Therapy Requires C5a-Mediated Neutrophil Chemotaxis via Regulation of Decay-Accelerating Factor CD55. Cancer Research. 67(15). 7421–7430. 40 indexed citations
14.
Salvador, Carolina, et al.. (2007). Cytotoxicity of bevacizumab is enhanced by β-glucan in tumors expressing membrane-bound VEGF. Journal of Clinical Oncology. 25(18_suppl). 3060–3060. 1 indexed citations
15.
Yan, Jun, Bing Li, Daniel J. Allendorf, et al.. (2006). Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via CR3-Syk-PI3-kinase pathway.. Cancer Research. 66. 1309–1309. 2 indexed citations
16.
Li, Bing, Daniel J. Allendorf, Richard Hansen, et al.. (2006). Yeast β-Glucan Amplifies Phagocyte Killing of iC3b-Opsonized Tumor Cells via Complement Receptor 3-Syk-Phosphatidylinositol 3-Kinase Pathway. The Journal of Immunology. 177(3). 1661–1669. 149 indexed citations
17.
Grimes, H. Leighton, Carrie L. Schanie, Yiming Huang, et al.. (2004). Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Experimental Hematology. 32(10). 946–954. 33 indexed citations
18.
Xu, Hong, Beate G. Exner, Daniel Cramer, et al.. (2002). CD8+, αβ-TCR+, and γδ-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow. The Journal of Immunology. 168(4). 1636–1643. 23 indexed citations
19.
Mueller, Yvonne M., Daniel Cramer, Yiming Huang, Beate G. Exner, & Suzanne T. Ildstad. (2002). Hematopoietic stem cells from the marrow of mice treated with flt3 ligand are significantly expanded but exhibit reduced engraftment potential1. Transplantation. 73(8). 1177–1185. 7 indexed citations
20.
Huang, Yiming, Daniel Cramer, Mukunda B. Ray, et al.. (2001). THE ROLE OF ????- AND ????-T CELLS IN ALLOGENEIC DONOR MARROW ON ENGRAFTMENT, CHIMERISM, AND GRAFT-VERSUS-HOST DISEASE1. Transplantation. 72(12). 1907–1914. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin P. Thornton Breakdown of academic impact, for papers by Yoshiaki Fujimiya Breakdown of academic impact, for papers by Margareta Hanikýřová Breakdown of academic impact, for papers by Judith A. Cain Breakdown of academic impact, for papers by J.P. Pivel Breakdown of academic impact, for papers by Ling Zeng Breakdown of academic impact, for papers by Kayoko Suzuki Breakdown of academic impact, for papers by Rong‐Hwa Lin Breakdown of academic impact, for papers by Guang‐Yuh Hwang Breakdown of academic impact, for papers by T Taniyama
Rankless by CCL
2026